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860Objective: Surgical ablation of atrial fibrillation is generally safe and effective, but atrial fibrillation redevelops in
approximately 20% of patients. We sought to determine anatomic factors, technology factors, or both that
contribute to these failures.
Methods: Four hundred eight patients underwent 5 types of atrial fibrillation ablation depending on their atrial
fibrillation history and need for concomitant surgical intervention: the classic maze procedure, high-intensity
focused ultrasound, the left atrial maze procedure, the biatrial maze procedure, and pulmonary vein isolation.
Ninety-five percent of patients with preoperative atrial fibrillation underwent surgical ablation.
Results: Patients undergoing high-intensity focused ultrasound had a high rate of late postoperative percutaneous
ablation (37.5%) after surgical intervention (P<.001 vs the other groups). At last follow-up, freedom from atrial
fibrillation and need for ablation was as follows: classic maze procedure, 90%; high-intensity focused ultrasound,
43%; left atrial maze procedure, 79%; biatrial maze procedure, 79%; and pulmonary vein isolation, 69%
(P< .001 between groups). For those with atrial fibrillation, mapping and ablation were performed in 23.6%
(n ¼ 27), and all patients with high-intensity focused ultrasound had failure of the box lesion around the pulmo-
nary veins. Of those with just the left atrial maze procedure or pulmonary vein isolation, the right atrium was the
source for failure in 75% (6/8).
Conclusions: Patients undergoing high-intensity focused ultrasound had a high need for postoperative ablation
and low freedom from atrial fibrillation. The classic maze procedure had the best results. Left atrial ablation might
allow failure from right atrial foci. Matching the technology and lesion set to the patient yields good results and can
be applied in 95% of patients.We suggest others obtain late catheter ablation to correct remaining atrial fibrillation,
and add to the paucity of late data regarding failure mode. (J Thorac Cardiovasc Surg 2010;139:860-7)Earn CME credits at
http://cme.ctsnetjournals.org
Surgical ablation of atrial fibrillation (AF) has become the
standard of care with concomitant surgical intervention.
Publications have shown that preoperative AF in patients
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The Journal of Thoracic and Cardiovascular Surgment (AVR), is an independent risk factor for late deleteri-
ous effects, including major adverse cardiac events and
reduced survival.1-5 A report from the Society of Thoracic
Surgeons (STS) database documented the increasing
frequency of AF ablation (the maze procedure or its
variations) at the time of concomitant surgical intervention.6
AF was present preoperatively in 11% of patients undergo-
ing heart surgery in the STS database. Concomitant AF
ablation surgery increased from 28.1% in 2004 to 39% in
2007 and was performed during MV surgery (in those
with preoperative AF) in 54.7% of cases. The STS study
indicated that adding AF ablation added 9 minutes of
cross-clamp and cardiopulmonary bypass time without in-
creased morbidity or mortality.6 Six prospective randomized
trials have also demonstrated a statistically significantly bet-
ter return to sinus rhythm (44% to 94%) for those patients
who were treated with AF ablation versus control sub-
jects.7,8 A combined document from the Heart Rhythm So-
ciety and the STS concluded that appropriate indications for
surgical AF ablation are as follows: patients with symptom-
atic AF undergoing other cardiac surgical procedures; select
patients with asymptomatic AF undergoing other cardiac
surgery; and stand-alone AF surgery for patients with symp-
tomatic AF who prefer a surgical approach, have undergoneery c April 2010
Abbreviations and Acronyms
AAD ¼ antiarrhythmic drug
AF ¼ atrial fibrillation
AFL ¼ atrial flutter
AT ¼ atrial tachycardia
AVR ¼ aortic valve replacement
CAB ¼ coronary artery bypass
EP ¼ electrophysiology
HIFU ¼ high-intensity focused ultrasound
LA ¼ left atrial
MV ¼ mitral valve
PVI ¼ pulmonary vein isolation
RF ¼ radiofrequency
STS ¼ Society of Thoracic Surgeons
TV ¼ tricuspid valve
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didates for catheter ablation.7 Although the document
sought to come up with some standardized way of reporting
success or freedom from AF, it is a complex subject, and
a separate article from the STS also provided guidelines.7,9
From the literature, it appears that failures occur in
approximately 20% of patients who undergo AF ablation
with MV surgery.7,8 Risk factors for failure have been deter-
mined to be increased left atrial (LA) size, increased age,
longer duration of AF, permanent AF, more limited ablation
lesion sets, and others.10-14 Surgical ablation lines are
largely applied based on the anatomy, whereas catheter tech-
niques follow anatomic boundaries but are supplemented
with direct mapping data to identify trigger points. In this
report we hypothesize that there might be patterns of failure
of the surgical ablation techniques. We suspect that failures
might be related to incomplete transmural lines or incom-
plete lesions sets (eg, right atrial origin following LA
lesions). Therefore in this report we analyze the patterns of
ablation failure and determine whether there are identifiable
causes, such as incomplete lesion sets or unreliable technol-
ogies. If the patterns of failure can be identified, then poten-
tially other interventions, such as additional lesion sets, new
or different technologies, or a more vigorous effort to create
full complete transmural lesions, might improve the results
of AF ablation surgery.
MATERIALS AND METHODS
From April 1, 2004, until December 31, 2008, 430 patients with a preop-
erative history of AF presented for surgical intervention, and 94.9%
(n ¼ 408) underwent AF ablation either as stand-alone AF surgery
(13.7%, n ¼ 56) or concomitant to other cardiac operations (86.3%,
n¼ 352). A single surgeon (PMM) was chosen for this report to standardize
the approach to the lesion set. Patients were entered into an institutional
review board–approved study (no. 1532-003, Cardiac Surgery Outcomes
Registry and N-CORE-STU00008001). It allowed retrospective and pro-The Journal of Thoracic and Caspective collection of preoperative and perioperative data, as well as early
and late outcomes.
These patients have been prospectively followed since January 2006,
when a dedicated AF clinical/research nurse was hired. The postoperative
AF management protocol was standardized in collaboration with electro-
physiologists. Patients were discharged on antiarrhythmic drugs (AADs)
and anticoagulant medication if not contraindicated (eg, drug intolerance).
For any patients with persistent atrial flutter (AFL) or AF past 1 month,
cardioversion was recommended. Mobile cardiac outpatient telemetry (Car-
dioNet, CardioNet, Conshohocken, Pa, or ACTAmbulatory Cardiac Telem-
etry, LifeWatch Corp, Rosemont, Ill) was recommended at 3 months, and if
this was not available, attempts were made to have the patient wear an AF
Express (LifeWatch Corp) monitor for 30 days or a Holter monitor at the
cardiologist’s discretion. Patients with dual-chamber implanted defibrilla-
tors or pacemakers had mode-switch parameters activated to track atrial
arrhythmias. Monitor results were also obtained from cardiac rehabilitation
sessions. AADs were withdrawn at the discretion of the cardiologist and AF
nurse if sinus rhythm was documented at 3 months. Patients with persistent
AFL, AF, or atrial tachycardia (AT) were offered referral to electrophysiol-
ogy (EP) for catheter ablation. Monitoring with mobile cardiac outpatient
telemetry or 30-day event monitors were performed again at 6 months,
and anticoagulation was discontinued for patients maintaining sinus rhythm
off AADs at the discretion of the cardiologist. Patients and the referring
cardiologists were given copies of these guidelines, and telephone follow-
up was made with patients within the first month and again at 3, 6, and
12 months to track progress. Patients participating in the Cardiac Surgery
Outcomes Registry were sent surveys at 3, 5, and 12 months and annually.
Copies of medical records were obtained for any procedures or hospitaliza-
tions to verify self-reported events.
Of the group who underwent concomitant surgical intervention (Tables
1 and 2), the operations primarily consisted of MV surgery (65.4%,
n ¼ 267) but were diverse, including tricuspid valve (TV) surgery, AVR,
and CAB. Eighty-seven (21.3%) patients were undergoing reoperations.
Of those with a history of AF, 94.9% underwent ablation at the time of
the operation. The reasons not to add AF ablation surgery were that the ad-
dition of AF surgery was thought to increase the risk of the operation or du-
ration of the operation, with the perception that there would be little benefit
to the patient.
The classic ‘‘cut-and-sew’’ maze procedure (maze III) was performed
for young patients with symptomatic AF, many of whom (44.1%,
n ¼ 30) had undergone failed percutaneous catheter ablation. This also
was applied in some patients with severe LA dilatation in whom the cut-
and-sew technique allowed atrial reduction, which reports indicate
improves the effectiveness of the procedure.15 Another group of patients
were undergoing MV surgery, and in this group an LA maze procedure
was performed, consisting of a box lesion of all 4 pulmonary veins and
an MV annular lesion connected to the pulmonary vein isolation (PVI)
lesion (LA isthmus lesion). Typically, this approach was used for patients
with recent-onset or paroxysmal AF and for patients in whom there was
no need to otherwise open the right atrium. A biatrial lesion set was chosen
for patients with long-standing AF, patients with symptomatic AF, young
patients, or those undergoing right-sided operations (typically TV repair).
Also, there was much more use of the biatrial procedure after publication
of a meta-analysis indicating better results with biatrial rather than just
LA lesions (Figure 1).7,12 Finally, after favorable reports from Europe,
ablating with high-intensity focused ultrasound (HIFU; St Jude Medical,
Inc, St Paul, Minn) was used for a limited period of time for patients under-
going stand-alone procedures using an off-pump minimally invasive proce-
dure through a lower sternotomy that included staple closure of the LA
appendage (n ¼ 16).16 In addition, HIFU was used with concomitant surgi-
cal intervention in 8 patients, including 3 undergoing CAB and 5 undergo-
ing MV procedures. The HIFU lesion set consisted of pulmonary vein box
lesions and also application of the epicardial ‘‘wand’’ to create a lesion to
the MV annulus (n ¼ 20), and additional right atrial lesions were maderdiovascular Surgery c Volume 139, Number 4 861
FIGURE 1. Maze procedure volume. After publication of a meta-analysis in 2006 showing greater freedom from AFwith a biatrial lesion set rather than just
a left atrial set, our practice changed, and biatrial procedures predominated.
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wand (n¼ 15). Conduction block testing was not routinely performed in any
of the groups. A variety of energy sources were used. For the majority of
cases (268/408 [65.7%]), bipolar radiofrequency (RF; either Medtronic,
Minneapolis, Minn, or AtriCure, Inc, West Chester, Ohio) clamps were
used, and at least 2 applications of the clamp per lesion were applied. For
most patients undergoing reoperative MV surgery (43/73 [58.9%]), cryoa-
blation with 25- and 5-mm probes (AtriCure, Inc [formerly Frigitronics, Inc,
Trumbull, Conn]) was used because the energy could be placed from the en-
docardial approach and did not require epicardial dissection of the adhe-
sions. For patients with biatrial lesions, a lateral right atriotomy wasTABLE 1. Preoperative characteristics
Classic maze
procedure HIFU PVI
No. of patients 68 (16.7) 24 (5.9) 50 (12.3)
Sex (male) 38 (55.9)* 20 (83.3) y 41 (82.0)
Age (y) 56.8  10.7 61.8  11.9 73.0  10
Congestive heart failure 12 (17.7)* 4 (16.7)* 15 (30.0)
NYHA class III and IV 12 (17.9)* 3 (12.5)* 16 (32.0)
Previous pacemaker 8 (11.8) 3 (12.5) 6 (12.0)
Diabetes 1 (1.5)* 0 (0.0)*,y 11 (22.0)
CVA 6 (8.8) 0 (0.0) 3 (6.0)
Pulmonary hypertension 21 (33.3)*,y 4 (16.7)* 16 (42.5)
Ejection fraction (%) 51.4  11.6* 50.9  9.9* 57.6  9
Left atrial size (cm) 4.4  0.9* 4.2  0.1* 4.1  0.
Aortic stenosis (moderate/
severe)
5 (7.4)* 2 (8.3)*,y 36 (72.0)
Mitral insufficiency (þ3/þ4) 14 (20.5) 5 (20.8) 1 (2.0)
Sick sinus syndrome 13 (19.1)* 6 (25.0)* 5 (10.0)
Type of AF
Persistent 1 (1.5)*,y 2 (8.3)z 2 (4.0)z
Permanent 33 (49.3)*,y 4 (16.7)z 12 (24.0)
Paroxysmal 33 (49.3)*,y 18 (75.0)z 36 (72.0)
AF duration (y) 7.4  7.1*,y 8.0  9.4* 4.0  4.
Data are presented as counts, with percentages in parentheses. Continuous data are show
pulmonary vein isolation; NYHA, New York Heart Association; CVA, cerebrovascular acc
862 The Journal of Thoracic and Cardiovascular Surgmade, and either bipolar RF or cryoablation was applied from the right at-
riotomy up to the superior vena cava and down to the inferior vena cava to
create another lesion. Cryolesions were placed from the coronary sinus to
the TV annulus and from the right atriotomy to the TV annulus. The classic
cut-and-sew lesions have been described elsewhere.17 For some patients un-
dergoing operations that did not require opening the left atrium (AVR and
CAB), especially in asymptomatic elderly patients, bilateral PVI with bipo-
lar RF clamps and closure of the LA appendage were performed to simplify
the procedure and yet reduce the AF risk.
Tables 1 and 2 organize the patients into groups by 5 lesion sets. Patients
undergoing the classic maze procedure and patients undergoing stand-aloneLeft-sided maze
procedure only
Biatrial maze
procedure Total P value
175 (42.9) 91 (22.3) 408
y 88 (50.3)* 42 (46.2)* 229 (56.1) <.0001
.7* 66.8  12.1y 68.7  10.3*,y 66.0  12.2 <.0001
*,y 83 (47.4)z 34 (38.5)y,z 149 (36.5) <.0001
*,y 71 (41.3)y 37 (41.1)y 139 (34.5) <.001
18 (10.3) 10 (11.0) 45 (11.0) >.2
z 22 (12.6)y,z 13 (12.3)y,z 47 (11.5) <.001
8 (4.6) 2 (2.2) 19 (4.7) >.2
y 102 (65.4) 42 (73.7) 186 (54.7) <.0001
.8y 53.0  11.2*,y 52.7  12.9*,y 53.1  11.5 .04
6* 4.7  0.8y 4.8  0.9y 4.6  0.9 <.001
35 (20.0)y 21 (23.1)y 99 (24.3) <.0001
133 (76.0) 58 (63.7) 211 (51.7) .16
*,y 15 (8.6)y 8 (8.8)y 47 (11.5) .04
4 (2.3)*,y 7 (7.7)y 16 (4.0)
z 54 (31.4)*,y 50 (55.0)y 153 (37.9)
z 111 (64.5)*,y 34 (37.4)y 232 (57.4)
9y 4.5  6.4*,y 7.3  8.2*,y 5.7  7.1 .001
n as means  standard deviations. HIFU, High-intensity focused ultrasound; PVI,
ident; AF, atrial fibrillation. *,y,zHomogeneous groups.
ery c April 2010
TABLE 2. Intraoperative and perioperative characteristics
Classic maze
procedure HIFU PVI
Left-sided maze
procedure only
Biatrial maze
procedure Total P value
No. of patients 68 (16.7) 24 (5.9) 50 (12.3) 175 (42.9) 91 (22.3) 408
CAB 2 (2.9) 5 (20.8)* 30 (60.0) 51 (29.1)* 24 (26.4) 112 (27.5) <.0001
MVR 22 (32.4)* 5 (20.8)* 2 (4.0) 162 (92.6) 76 (83.5) 267 (65.4) <.0001
AVR 3 (4.4)* 0 (0.0)* 42 (84.0) 42 (24.0)y 25 (27.5)y 112 (27.5) <.0001
TVA 12 (17.7)* 1 (4.2)* 3 (6.0)* 58 (33.3) 51 (56.0) 125 (30.6) <.0001
Reoperation 7 (10.3)* 0 (0.0)* 4 (8.0)* 47 (26.9)y 29 (31.9)y 87 (21.3) <.0001
Previous ablation 30 (44.1) 5 (20.8) 0 (0.00) 9 (5.2) 5 (5.6) 49 (12.1) <.001
Complications
Operative bleeding 1 (1.5) 0 (0.0) 2 (4.0) 7 (4.0) 0 (0.0) 10 (2.5) >.2
Deep sternal infection 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6) 0 (0.0) 1 (0.2) >.2
Permanent stroke 1 (1.5) 0 (0.0) 0 (0.0) 2 (1.1) 2 (2.2) 5 (1.2) >.2
Transient ischemic attack 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6) 2 (2.2) 3 (0.7) >.2
Coma 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6) 0 (0.0) 1 (0.2) >.2
Prolonged vent 1 (1.5) 0 (0.0) 3 (6.0) 18 (10.3) 9 (9.9) 31 (7.6) .07
Dialysis required 0 (0.0) 0 (0.0) 1 (2.0) 6 (3.4) 2 (2.2) 9 (2.2) >.2
Heart block 4 (5.9) 0 (0.0) 1 (2.0) 12 (6.9) 11 (12.1) 28 (6.9) .15
LOS (d) 5.0 (5.0–7.0)* 5.0 (4.0–7.0)* 6.0 (5.0–8.0)*,y 7.0 (5.0–9.0)y 7.0 (6.0–9.0)y 6.0 (5.0–8.0) <.001
In-hospital mortality 0 (0.0) 0 (0.0) 1 (2.0) 4 (2.3) 0 (0.0) 5 (1.2) >.2
30-d Mortality 0 (0.0) 0 (0.0) 1 (2.0) 4 (2.3) 2 (2.2) 7 (1.7) .19
Discharge rhythm: AF/AFL 4 (5.9) 11 (45.8)* 17 (34.0)*,y 39 (22.3)y 27 (29.7)*,y 98 (24.0) <.001
Rhythm follow-up (mo)z 15 (4-13) 22 (14-35) 9 (4-16) 13 (6-26) 8 (4-13) 12 (6-24)
No. of ablations/failure>90 d 3/8 (37.5) 9/14 (64.2) 2/14 (14.3) 6/53 (11.3) 7/25 (28) 27/114 (23.6)
Data are presented as counts, with percentages in parentheses. Continuous data are shown as medians, with interquartile ranges in parentheses. HIFU, High-intensity focused
ultrasound; PVI, pulmonary vein isolation; CAB, coronary artery bypass;MVR, mitral valve repair/replacement; AVR, aortic valve replacement; TVA, tricuspid valve annuloplasty;
LOS, length of stay. *,yDenotes homogeneous groups. zDuration of follow-up is shown as the median, with the interquartile range in parentheses.
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groups. The group undergoing the LA and biatrial maze procedures were
typically older patients who required valve surgery.
Patients’ characteristics were compared by using analysis of variance
and Student–Newman–Keuls post hoc tests for continuous variables.
Continuous variables were summarized as means  standard deviations
or medians and interquartile ranges. Length of stay was positively skewed,
and therefore a natural logarithm transformation was applied to this variable
before analyses. Categorical variables were analyzed by using c2 and
Fisher’s exact tests for both omnibus and post hoc comparisons.
Time to first postsurgical catheter ablation for the different maze proce-
dure types was plotted by using Kaplan–Meier curves. The differences in
survival times to first ablation were compared with the log-rank test.
Recurrence of AF/AFL/AT among surgical groups was compared in 3
ways. First, the rhythm documented on the last follow-up outside of the
90-day blanking window after surgical intervention was used to indicate
freedom from AF, AFL, or AT. Proportions of patients by AF surgery
type were compared by using c2 tests. Second, we also estimated 1-year
AF-free survival for patients with at least 1 rhythm available in the 8- to
15-month window after surgical intervention. Again, the last available
rhythm was used to determine the success of AF surgery. Finally, catheter
ablation was combined with AF, AFL or AT at the time of the last follow-up
to define ablation failure. The c2 method was used to analyze this aggregate
end point.
A 2-tailed significance level of 5% was used for all comparisons.
RESULTS
Thirty-day mortality was 1.7%, 0% for stand-alone AF
surgery, and 0% for primary MV/maze procedure
(n ¼ 194). Follow-up was 95% complete, and median
follow-up was 12 months, with an interquartile range ofThe Journal of Thoracic and Ca5.5 to 24 months (Table 2). Perioperative complications
included permanent stroke in 1.2%, transient ischemic
attack or reversible ischemic neurologic deficit in 0.7%,
placement of a new pacemaker in 6.9%, and reoperation
for bleeding in 2.5%. No complications were related to
AF ablation. Mean length of stay was 6.0 days and was
shortest for the classic maze procedure and HIFU
(P < .001 between groups, Table 2). Discharge rhythm
was AF or AFL in 24% (n¼ 98) and was significantly lower
for the classic maze procedure (5.9%, P<.001). At the most
recent follow-up (beyond the 3- to 6-month weaning period),
16.1% of patients were taking AADs, and 43.6% were
receiving warfarin anticoagulation.
At 12 months, freedom from AF was 85% (n ¼ 177)
overall. By using this method, there was no significant dif-
ference (P ¼ .254) between groups, and success varied
from 73% to 94% (Table 3). By most recent rhythm, it
was 83.3% (n ¼ 347) and varied (P ¼ .016) from 72% to
95%. When ablations were added to the failure count, the
overall AF-free rate was 78% and varied (P<.001) between
43% for HIFU and 0% for the classic maze procedure.
After the perioperative inflammatory effects were allowed
to subside (3 months), catheter mapping and ablation were
suggested for patients with recurrent AF or AFL if they
had symptoms or other indications to seek return of sinus
rhythm. Catheter ablation was performed in 23.6% of these
patients and varied among groups, being highest for HIFUrdiovascular Surgery c Volume 139, Number 4 863
TABLE 3. Freedom from AF/freedom from AF and ablation
Interval
contact, 12 mo Last F/U*
Last F/U,
no ablationy
Group
Classic maze procedure 94% 95% 90%
HIFU 73% 73% 43%
Biatrial maze procedure 85% 87% 79%
LA maze procedure 85% 81% 79%
PVI 73% 72% 69%
Total 85% 83% 78%
F/U, Follow-up; HIFU, high-intensity focused ultrasound; PVI, pulmonary vein isola-
tion. *P ¼ .016. yP< .001.
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[77.8%]) were performed at Northwestern Memorial Hospi-
tal. Records were obtained for 3 of the 6 patients who had
ablations performed elsewhere and were supplemented as
necessary with further information from the EP analysis.
Of the 24 patients who had HIFU ablation, 37.5% (n¼ 9)
had ablation. Mapping disclosed that there was a failure of
the encircling lesion in 100% of patients. Other sources
for failure included macroreentry arrhythmias in the right
atrium (n ¼ 4). Among the 9 patients, 13 cardioversions
were performed either before ablation or between ablation
attempts. One patient had 2 ablations. One patient had right
AFL ablated, and LA arrhythmias were identified but not
treated. Five of the patients achieved sinus rhythm after ab-
lation, ablation failed in 2 patients, and the outcome is un-
known for 2 patients.
Of those who had PVI, catheter ablation was performed
in 4% (n ¼ 2). In these patients no failure of PVI wasFIGURE 2. Freedom from ablation. Patients undergoing HIFU had early fail
(P< .001) than patients in the other groups. AF, Atrial fibrillation; HIFU, high-
864 The Journal of Thoracic and Cardiovascular Surgidentified. The location for arrhythmia was the cavotricuspid
isthmus in both patients. One patient had a cardioversion be-
fore ablation. One of the patients achieved sinus rhythm after
ablation. The outcome of the second patient is unknown.
Of those who had the classic maze procedure, 4.4%
(n ¼ 3) had follow-up ablation. Among these patients, fail-
ure of right upper PVI (despite cut-and-sew lesions) was
identified in 1 patient. Failure of the MV isthmus line was
identified in 2 patients. Other arrhythmias were macroreen-
try within the right atrium. Among the 3 patients, a cardiover-
sion was attempted before ablation in 2 patients. No patients
had multiple ablations after the maze procedure, and all
achieved sinus rhythm.
Of those who underwent the LA maze procedure, 3.4%
(n¼ 6) had follow-up ablation. Failure of the PVI box lesion
was identified in 1 patient (cryoablation in a reoperation).
Other sources for failure included the MV isthmus lesion
in 2 patients and right atrial focus in 5 patients. Among
the 6 patients, 2 cardioversions were performed before the
ablation attempt. No patients had more than 1 ablation,
and 3 patients achieved sinus rhythm. Ablation failed in 2
patients, and the outcome of 1 patient is unknown.
Of those who had biatrial lesion sets, 7.7% (n ¼ 7) had
catheter ablation. Of these, 5 patients had failure of the
box lesion; 2 patients had failure of the MV isthmus lesion.
Two patients had failure of the right atrial lesion, and 1 pa-
tient had focal right AT. Among the 7 patients, 6 cardiover-
sions were performed. Three patients had more than
1 ablation procedure; 6 patients achieved sinus rhythm,
and ablation failed in 1 patient. Overall, of the 27 patients
who had ablation, 18 (67%) achieved sinus rhythm.ure with symptomatic recurrence and underwent ablation more commonly
intensity focused ultrasound; PVI, pulmonary vein isolation.
ery c April 2010
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The principal findings of this study confirm the general
success of surgical treatments for AF with a low periopera-
tive risk and 84% off AADs at the last follow-up, that there
was a high failure rate using HIFU technology related to
incomplete transmural encircling lesions, that LA lesions
alone allow for AF failure from right atrial foci, and that
the mitral isthmus lesion is another potential source of fail-
ure. Unlike some other surgical studies, this was a ‘‘real-
world’’ study using various techniques and technologies
adapted for a variety of concomitant or stand-alone opera-
tions. This series also benefited from a prospective, proto-
col-driven approach to patients after recruiting an AF
nurse specialist starting in 2006.
Determining success is always problematic, but the clas-
sic maze procedure had a low rate of ablation in follow-
up, and 95% were free from AF at last follow-up. This
was usually performed for very symptomatic, relatively
young patients (mean age, 57 years); 44% had prior abla-
tion, and 49% had permanent AF. On the other hand,
HIFU was also performed frequently for symptomatic AF
(mean age, 62 years), and only 18% had permanent AF
(75% had paroxysmal AF). Ablation after surgical interven-
tion was required much more commonly (37.5%) in the
HIFU group than for other surgical groups, and at the last
follow-up, only 73% of patients undergoing HIFU were
free of AF. Some studies have also shown better results
with the classic maze procedure than with bipolar RF,18
although others have found similar results with the classic
and maze IV bipolar RF–assisted surgery.19 Our freedom
from AF rate for HIFU is a little lower than that seen in pub-
lished reports,16,20 and to achieve that success required
a high rate of postoperative ablation. Other HIFU series
included patients undergoing MV surgery with a history of
preoperative paroxysmal AF, a group who frequently return
to sinus rhythm without any AF ablation. In contrast, our
HIFU series included many symptomatic patients with AF
seeking an off-pump, minimally invasive treatment. If these
patients return to AF, they are likely to seek further ablation
for AF. However, in the classic maze group, who were also
very symptomatic, only 4.4% had postoperative ablation.
We abandoned HIFU in 2005 based on the findings from
mapping at the time of ablation.
EP mapping in the HIFU group was instructive in that the
box lesion was incomplete or no ablation line could be iden-
tified in any patient. The cause for failure can only be specu-
lated; whether it was from inadequate device contact with the
left atrium, device malfunction, bubbles in the stream of sa-
line that would disperse the ultrasound wave, or some other
issue is unknown. However, the anatomic pattern of failure
was very consistent in all patients undergoing HIFU who un-
derwent mapping and was much different from that of any
other AF ablation lesion set group or technology.The Journal of Thoracic and CaNot surprisingly, if LA ablation only is performed, then
there is a risk for failure because of right atrial sources.
Excluding the patients undergoing HIFU discussed above
and excluding patients undergoing the biatrial and classic
maze procedures (who have right atrial ablation lesions),
there were right-sided foci in 6 of the 8 mapped patients
with just LA lesions or PVI. There were other foci in the
LA group as well (mitral isthmus in 2 and cryoablation
failure of the box lesion in 1 reoperation). Although this
shows a high rate of right atrial lesions at mapping, this com-
prises only 8 of the 225 patients who had PVI or the LA
maze procedure, and freedom from AF at last follow-up
was consistent with most literature reports (81% for the
left-sided maze procedure and 72% for PVI). Nevertheless,
to increase effectiveness, it would make sense that more
right-sided lesions will improve effectiveness, and this
appears to be the case, with 95% and 87% free from AF
at last follow-up for classic maze and biatrial lesions. This
has also been reported by a meta-analysis showing 87.1%
to 92.0% effectiveness for biatrial lesions versus 73.4% to
86.1% for just LA lesions.12 As a practical matter, however,
a surgeon might not be willing to perform those lesions. For
instance, in elderly patients (average age, 73 years in the PVI
group and 67 years in the left-sided maze group) with fragile
tissue, the right atriotomy might add some bleeding risk and
add to the operative time. Especially for a patient with
paroxysmal AF (72% in the PVI group and 65% in the
left-sided maze procedure group), who might return to sinus
rhythm anyway, it might not be worth that risk. Biatrial
lesions were chosen more commonly for those with perma-
nent or persistent AF (63%).
In total, 334 patients had a mitral isthmus line placed
(classic maze procedure, n ¼ 68; left maze procedure,
n ¼ 175; biatrial maze procedure, n ¼ 91), and of these,
mapping and ablation were performed in 16. Of these, fail-
ure of the mitral isthmus was identified in 6 (38%) patients.
Also, 7 (44%) patients (5 in the biatrial group done with
bipolar RF, 1 undergoing cryoablation in the LA group,
and 1 undergoing the classic maze procedure) had failure
of the PVI or box lesion. This seems to be a good track
record and might be explained by the predictability of the
RF clamps.19 One patient undergoing the classic maze pro-
cedure had a reported failure of the PVI at the right upper
pulmonary vein 9 months after the operation. Because this
was an early failure after the cut-and-sew maze procedure,
it cannot be explained by lack of transmurality or reinnerva-
tion across the suture line. We hypothesize that the left
atriotomy in Waterston’s groove was made partially in the
right upper pulmonary vein and might have left pulmonary
vein tissue on the LA side that could serve as a trigger.
EP reports of findings after surgical treatment of AF
included allegedly cut-and-sew maze procedures (there
were no surgeon coauthors on this article), and therdiovascular Surgery c Volume 139, Number 4 865
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ious centers.21 Failure of the box lesion and incisional AFL
were found more frequently in this series.21 Atypical electro-
cardiographic appearance of flutter after the maze procedure
was common, making rhythm diagnosis difficult from sur-
face recordings, as discussed in another article.22 EP map-
ping confirmed the mitral annulus and cavotricuspid
isthmus as common sites of failure, and ablation success-
fully treated these rhythms.22 We suggest that others also
try to obtain late catheter ablation to correct remaining AF
and add to the paucity of late data regarding failure mode.
Also, successful ablation was achieved in 67% of our
patients.
This report is limited in that only those patients who
returned for mapping provided information; most asymp-
tomatic patients would not return for mapping. Also, the
PVI group was older, and other mechanisms (eg, failure of
the PVI lesions) might be underreported. Conceivably,
patients with asymptomatic recurrences who did not seek
ablation might have had different mechanisms, although
there is no reason to suspect that. Althoughmost of the group
was followed prospectively, for 18 months before 2006,
management of the patients was less directed, and follow-
up was retrospective. This would not affect the EP findings,
however.
In summary, late mapping and ablation found a high rate
of failure with HIFU for patients with AF undergoing stand-
alone operations. Isolated left-sided surgical procedures
allow for right-sided sources of AF that might cause symp-
tomatic failure. We now perform more biatrial procedures,
especially if the right atrium needs to be opened anyway
(eg, tricuspid surgery). Mitral isthmus failure and failure
of PVI or the box lesion can occur, and care must be taken
to create complete transmural lesions. Because of a low
need for late ablation and the high success rate of the classic
maze procedure, it is still the gold standard procedure for
symptomatic patients.
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Dr Chuen-Neng Lee (Singapore, Singapore). Where does AF
surgery fail? I think this is a complex and difficult subject, and
Dr McCarthy should be complimented for providing information
on this subject. This study has several problems. There is obvious
inherent patient selection bias with significantly differing subsets,
each of which have different mechanisms for AF. The study design
is complicated, attempting to delineate 5 techniques (3 different
surgical approaches), each with a modality of having inherent
modes of failure, different ability to deliver transmurality, inade-
quate design of the instrument, and varying ability to produce
lesion sets.
The study is further complicated by having 4 ways to compare
outcomes, and the study was switched halfway from a retrospective
study to a prospective study. It is unclear what percentage of the pa-
tients actively returned for mapping in each category, although it
seemed to be a very small minority. No mention was made of the
results of cryoablation versus RF ablation.ery c April 2010
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failure, but at the end of the day, the choice of AF techniques
remained a maze procedure. I think further work will need to be
focused on this mechanism.
I have just one question for DrMcCarthy.What are the statistical
power and a numbers needed for such a study with varying subsets
of patients? Did we achieve this with the 408 patients we have in
this series?
Thank you.
DrMcCarthy. Thanks, Dr Lee. First, it is a complex study in that
it reflects the reality of the complexity of the patients we face every
day. For instance, a simple study would be to do a classic maze pro-
cedure on all comers, but of course, that is not realistic because you
are not going to do that in an 82-year-old patient undergoing a redo
double-valve operation.Another overly simple studywould be to do
PVI in all patients, but that would not reflect the needs of very symp-
tomatic patients who failed catheter ablation and were referred
for surgical intervention. Therefore this study reflects what cardiac
surgeons see every day and how can they best treat these patients.
We did transition from a retrospective to a prospective study 16
months after the beginning of the study, but the AF nurses then
went back and aggressively followed up with all the patients
from before to put them into the protocol. Therefore they are not
‘‘lost,’’ as many patients are in a retrospective study.
The statistical question I did not totally understand about how
many patients we would need in different groups. I was not clear
about that question. Could you repeat that?
Dr Lee. To differentiate so many different modalities of treat-
ment, do you have enough numbers to tell the difference statisti-
cally?
Dr McCarthy. No, we did not ask the statistician, for instance,
how we would be able to do that in terms of determining howmany
patients in each group would need to be put into different groups to
randomize that. We just asked him to analyze the patient group that
we had actually studied.
Dr Niv Ad (Falls Church, Va). Pat, I enjoyed your presentation,
and I think it is a very important one. Because you were one of the
first adopters of HIFU, and obviously the technology failed, do you
have any conclusions regarding the next technology coming to your
hospital? Will it change anything in the way you assess technology
and adopt it?
Dr McCarthy. Good question. We were disappointed with
HIFU. I know they are still working on it to try to tweak it and
make it better. I still, as discussed yesterday, am a big believer in
bipolar RF and also cryoablation. Therefore the vast majority of
patients had those technologies applied to create the lesion sets,
as well as the cut-and-sew procedure. At this point, people have
tried things like lasers, but I believe that company is out of business,
and we have combined endocardial and epicardial approaches in
the laboratory that perhaps would be available for truly minimally
invasive procedures as sort of a hybrid approach, but all of that is
still in the design phase. We are still waiting for the perfect technol-
ogy that we will be able to use to do truly port-access, minimally
invasive AF surgery.
Dr Jason Sperling (Ridgewood, NJ). Thanks, Dr McCarthy.
Great talk. I have 2 questions. One is technical and relates to the
failures in the LA isthmus. Specifically, I was interested to know
what your technique was in the isthmus. Did you cut down ontoThe Journal of Thoracic and Cathe coronary sinus itself and cryoablate the coronary sinus, or
was this just cryoablation over the region endocardially? The sec-
ond question is related to the HIFU failures. To your recollection,
is there any chance that all or a lot of those ablation line failures
were in the dome of the left atrium given that the technique went
through the transverse sinus as opposed to being directly on the
dome? Perhaps that was a modality of failure?
Dr McCarthy. The technique to the MV annulus for the classic
maze procedure was cut-and-sew to the MV annulus, but we also
would apply cryoablation over it. For the others, we did not actually
take a knife and open to theMV annulus but used cryoablation with
a 5-mm Frigitronics probe, and in the last approximately 80 pa-
tients, we have been using 2 Frigitronics probes next to each other
to create a very wide line after we found some failures of the MV
annulus lesion.
The failures of HIFU varied. There were some in which there
was no evidence at all that there had been a line created. In others
where there was evidence of block, it appeared that the break-
through was most commonly near the left upper pulmonary vein.
Because the HIFU creates a round cinch but the atria is actually
more oblong, we thought that perhaps it would not have been
very good contact with the atrial wall in the round cinch, perhaps
on the part farthest away from the surgeon, and you would not
have been able to see that very well.
Dr Thorsten Hanke (Lu¨beck, Germany). In the HIFU group
most of the patients seemed to have a fairly high grade of mitral
regurgitation. Were those also the patients with an enlarged left
atrium, so that maybe that is why they had a high failure rate? In
the operating room did you check for conduction block? Maybe
those patients could have been selected before.
Dr McCarthy. We go into the HIFU group to a greater extent
in the manuscript. The majority of those patients actually under-
went stand-alone procedures. Of the patients who did have MV
surgery, they were typically myxomatous patients with a high
grade of mitral regurgitation, and they did have a more dilated
left atrium. However, most patients undergoing HIFU were
actually patients undergoing stand-alone procedures with mild
LA enlargement.
We did check for conduction block in the operating room in the
patients undergoing HIFU from the right-sided pulmonary veins,
but we were doing minimally invasive, very small incisions, lower
sternotomy, and we could not get access to the left-sided pulmonary
veins and check conduction block at that point.
Dr Sacha Salzberg (Zurich, Switzerland). Dr McCarthy, I saw
that in your PVI group there were 28% of patients who had either
persistent or permanent AF. Was that because these patients were
too high risk to undergo a long procedure; is it a selection bias?
Because in starting an AF program we often get comments that
this 85-year-old man who needs an AVR and has persistent AF,
well, let’s try and decrease the clamp time and get out as quickly
as possible. I wonder whether you could comment on that.
Dr McCarthy. The PVI group had a relatively small number of
patients, and PVI was used for patients who were older, undergoing
operations in whom we were not otherwise opening the left atrium.
Therefore that would typically be that older patient population with
AVR or CAB. Occasionally, we would also use it in that group be-
cause they had only paroxysmal AF. Therefore there was selection
bias. That was the technique we chose for that group.rdiovascular Surgery c Volume 139, Number 4 867
